Literature DB >> 25505059

MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus.

Eleonora Forte1, Archana N Raja1, Priscilla Shamulailatpam1, Mark Manzano1, Matthew J Schipma2, John L Casey3, Eva Gottwein4.   

Abstract

UNLABELLED: The human oncogenic Kaposi's sarcoma-associated herpesvirus (KSHV) expresses a set of ∼20 viral microRNAs (miRNAs). miR-K10a stands out among these miRNAs because its entire stem-loop precursor overlaps the coding sequence for the Kaposin (Kap) A/C proteins. The ectopic expression of KapA has been reported to lead to transformation of rodent fibroblasts. However, these experiments inadvertently also introduced miR-K10a, which raises the question whether the transforming activity of the locus could in fact be due to miR-K10a expression. To answer this question, we have uncoupled miR-K10a and KapA expression. Our experiments revealed that miR-K10a alone transformed cells with an efficiency similar to that when it was coexpressed with KapA. Maintenance of the transformed phenotype was conditional upon continued miR-K10a but not KapA protein expression, consistent with its dependence on miRNA-mediated changes in gene expression. Importantly, miR-K10a taps into an evolutionarily conserved network of miR-142-3p targets, several of which are expressed in 3T3 cells and are also known inhibitors of cellular transformation. In summary, our studies of miR-K10a serve as an example of an unsuspected function of an mRNA whose precursor is embedded within a coding transcript. In addition, our identification of conserved miR-K10a targets that limit transformation will point the way to a better understanding of the role of this miRNA in KSHV-associated tumors. IMPORTANCE: Kaposi's sarcoma-associated herpesvirus (KSHV) is a human tumor virus. The viral Kaposin locus has known oncogenic potential, which has previously been attributed to the encoded KapA protein. Here we show that the virally encoded miR-K10a miRNA, whose precursor overlaps the KapA-coding region, may account for the oncogenic properties of this locus. Our data suggest that miR-K10a mimics the cellular miRNA miR-142-3p and thereby represses several known inhibitors of oncogenic transformation. Our work demonstrates that functional properties attributed to a coding region may in fact be carried out by an embedded noncoding element and sheds light on the functions of viral miR-K10a.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25505059      PMCID: PMC4338870          DOI: 10.1128/JVI.03317-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  The duality of oncomiR addiction in the maintenance and treatment of cancer.

Authors:  Christopher J Cheng; Frank J Slack
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

2.  p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis.

Authors:  H Y Yang; R Shao; M C Hung; M H Lee
Journal:  Oncogene       Date:  2001-06-21       Impact factor: 9.867

3.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

Review 4.  CDK inhibitors: cell cycle regulators and beyond.

Authors:  Arnaud Besson; Steven F Dowdy; James M Roberts
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

5.  Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).

Authors:  S Muralidhar; G Veytsmann; B Chandran; D Ablashi; J Doniger; L J Rosenthal
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

6.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs.

Authors:  Yao-Tang Lin; Rodney P Kincaid; Dhivya Arasappan; Scot E Dowd; Scott P Hunicke-Smith; Christopher S Sullivan
Journal:  RNA       Date:  2010-06-21       Impact factor: 4.942

8.  p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho.

Authors:  Gregg A Wildenberg; Michael R Dohn; Robert H Carnahan; Michael A Davis; Nichole A Lobdell; Jeffrey Settleman; Albert B Reynolds
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

9.  Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque.

Authors:  A Gregory Bruce; Jonathan T Ryan; Mathew J Thomas; Xinxia Peng; Adam Grundhoff; Che-Chung Tsai; Timothy M Rose
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23.

Authors:  Mark Manzano; Priscilla Shamulailatpam; Archana N Raja; Eva Gottwein
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

View more
  17 in total

Review 1.  Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.

Authors:  S T F Bots; R C Hoeben
Journal:  Gene Ther       Date:  2017-05-09       Impact factor: 5.250

Review 2.  Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.

Authors:  Dirk P Dittmer; Blossom Damania
Journal:  J Clin Invest       Date:  2016-09-01       Impact factor: 14.808

Review 3.  Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis.

Authors:  Denis Avey; Brittany Brewers; Fanxiu Zhu
Journal:  Virol Sin       Date:  2015-04-23       Impact factor: 4.327

Review 4.  KSHV microRNAs: Tricks of the Devil.

Authors:  Jie Qin; Wan Li; Shou-Jiang Gao; Chun Lu
Journal:  Trends Microbiol       Date:  2017-03-02       Impact factor: 17.079

Review 5.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

6.  KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.

Authors:  W Zhang; S Hong; K P Maniar; S Cheng; C Jie; A W Rademaker; A M Krensky; C Clayberger
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

7.  Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.

Authors:  Mingqing Chen; Fan Sun; Lei Han; Zhaoxia Qu
Journal:  Oncotarget       Date:  2016-05-31

8.  KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.

Authors:  Minako Ikoma; Soren Gantt; Corey Casper; Yuko Ogata; Qing Zhang; Ryan Basom; Michael R Dyen; Timothy M Rose; Serge Barcy
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

9.  A Non-Coding RNA Network Involved in KSHV Tumorigenesis.

Authors:  Julián Naipauer; Martín E García Solá; Daria Salyakina; Santas Rosario; Sion Williams; Omar Coso; Martín C Abba; Enrique A Mesri; Ezequiel Lacunza
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

Review 10.  KSHV-Mediated Angiogenesis in Tumor Progression.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Roni Sarkar; Subhash C Verma
Journal:  Viruses       Date:  2016-07-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.